The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy, other indications, and future directions. Export

@article{citeulike:6091377, abstract = {Breast cancer is the most common non-skin type of cancer and the second leading cause of cancer mortality in women. Advances in diagnosis and treatment have led to declines in mortality, despite an increase in breast cancer incidence. An advancing array of both local and systemic therapy options has led to increasingly individualized treatment. Imaging plays a key role in detecting breast cancer and directing its therapy. This continuing education article provides a comprehensive review of current and future radiotracer imaging methods applied to breast cancer, in the context of breast cancer management strategies and other nonnuclear imaging methods. Part 1 of the review provided an overview of clinical and biologic considerations in breast cancer and covered radionuclide imaging for detection and staging. Part 2 covers radionuclide imaging of breast cancer response to therapy, other clinical indications for radionuclide breast cancer imaging, and future directions, including molecular imaging.}, author = {Lee, Jean H. and Rosen, Eric L. and Mankoff, David A.}, citeulike-article-id = {6091377}, citeulike-linkout-0 = {http://dx.doi.org/10.2967/jnumed.108.061416}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/19372493}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=19372493}, doi = {10.2967/jnumed.108.061416}, issn = {0161-5505}, journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine}, keywords = {breast, chemotherapy, kim\_, neoadjuvant, perspective, pet, review}, month = {May}, number = {5}, pages = {738--748}, posted-at = {2009-11-10 05:17:50}, priority = {2}, title = {The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy, other indications, and future directions.}, url = {http://dx.doi.org/10.2967/jnumed.108.061416}, volume = {50}, year = {2009} }

TY - JOUR ID - citeulike:6091377 L3 - citeulike-article-id:6091377 N2 - Breast cancer is the most common non-skin type of cancer and the second leading cause of cancer mortality in women. Advances in diagnosis and treatment have led to declines in mortality, despite an increase in breast cancer incidence. An advancing array of both local and systemic therapy options has led to increasingly individualized treatment. Imaging plays a key role in detecting breast cancer and directing its therapy. This continuing education article provides a comprehensive review of current and future radiotracer imaging methods applied to breast cancer, in the context of breast cancer management strategies and other nonnuclear imaging methods. Part 1 of the review provided an overview of clinical and biologic considerations in breast cancer and covered radionuclide imaging for detection and staging. Part 2 covers radionuclide imaging of breast cancer response to therapy, other clinical indications for radionuclide breast cancer imaging, and future directions, including molecular imaging. IS - 5 JF - Journal of nuclear medicine : official publication, Society of Nuclear Medicine SN - 0161-5505 EP - 748 TI - The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy, other indications, and future directions. VL - 50 SP - 738 KW - breast KW - chemotherapy KW - kim_ KW - neoadjuvant KW - perspective KW - pet KW - review AU - Lee, Jean AU - Rosen, Eric AU - Mankoff, David PY - 2009/05// UR - http://dx.doi.org/10.2967/jnumed.108.061416 ER -